← All trials
NCT05275738
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 18, 2022
- Primary completion
- Dec 31, 2026
- Completion date
- Dec 31, 2026
- First posted
- Mar 11, 2022
- Last posted
- Nov 3, 2022
- Enrollment
- 660
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Umea UniversityLead sponsor
- Duke UniversityCollaborator
- Lund UniversityCollaborator
- Singapore National Eye CentreCollaborator
- University of MelbourneCollaborator
- University of AdelaideCollaborator
- Karolinska InstituteCollaborator
- University of GothenburgCollaborator
- Linkoping UniversityCollaborator
- Centre for Eye Research Australia (CERA)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.